ANDA 65389, held by Epic Pharma. Demeclocycline Hydrochloride.
As of Nov 21, 2026, ANDA 65389 (Demeclocycline Hydrochloride), held by Epic Pharma, was first approved by FDA on Dec 1, 2008, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 1, 2008 | Original application | Approved | None posted |
| Demeclocycline Hydrochloride150MG · tablet;oral | Demeclocycline Hydrochloride | Rx |
| Demeclocycline Hydrochloride300MG · tablet;oral | Demeclocycline Hydrochloride | Rx |
| May 16, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Dec 1, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters